Significant MP calls for ICS Strains (ICS_001)  

 

Total number of results: 1094

Gene / Allele Procedure Parameter Zygosity Sex Phenotype P-value Graph
Cdk8
Cdk8tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E9.5 Embryo Size homozygote abnormal embryo size 0.0
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Gross Morphology Embryo E9.5 Severely Dysmorphic homozygote abnormal embryo development 0.0
Cdk8
Cdk8tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E9.5 Embryo turning homozygote abnormal embryo turning 0.0
Cdk8
Cdk8tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Cdk8
Cdk8tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Dbn1
Dbn1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Dbn1
Dbn1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Nxn
Nxntm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Nxn
Nxntm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Tmem63b
Tmem63btm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Tmem63b
Tmem63btm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ino80
Ino80tm1a(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ino80
Ino80tm1a(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Otub1
Otub1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Otub1
Otub1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Pigu
Pigutm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Pigu
Pigutm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Cdc26
Cdc26tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Cdc26
Cdc26tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Gatad2b
Gatad2btm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Gatad2b
Gatad2btm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Dcaf7
Dcaf7tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Dcaf7
Dcaf7tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Nlk
Nlktm2b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Nlk
Nlktm2b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Med25
Med25tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Med25
Med25tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Kctd15
Kctd15tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Kctd15
Kctd15tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Smc5
Smc5tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Smc5
Smc5tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Pax4
Pax4tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Pax4
Pax4tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Rwdd3
Rwdd3tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Rwdd3
Rwdd3tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Bmp10
Bmp10tm3b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Bmp10
Bmp10tm3b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Prps1
Prps1tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome hemizygote Female preweaning lethality, complete penetrance 0.0
Prps1
Prps1tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome hemizygote Male preweaning lethality, complete penetrance 0.0
Mbd5
Mbd5tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Mbd5
Mbd5tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ackr3
Ackr3tm2b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ackr3
Ackr3tm2b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Lcp2
Lcp2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Lcp2
Lcp2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Nrp1
Nrp1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Nrp1
Nrp1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Nol8
Nol8tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Nol8
Nol8tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Satb1
Satb1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Satb1
Satb1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Timm50
Timm50tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Timm50
Timm50tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Tgif2
Tgif2tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Tgif2
Tgif2tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Raf1
Raf1tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Raf1
Raf1tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Phf6
Phf6tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome hemizygote Female preweaning lethality, complete penetrance 0.0
Phf6
Phf6tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome hemizygote Male preweaning lethality, complete penetrance 0.0
Dnm1l
Dnm1ltm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Dnm1l
Dnm1ltm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Kdm5c
Kdm5ctm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome hemizygote Female preweaning lethality, complete penetrance 0.0
Kdm5c
Kdm5ctm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome hemizygote Male preweaning lethality, complete penetrance 0.0
Krt8
Krt8tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Krt8
Krt8tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Prdm10
Prdm10tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Prdm10
Prdm10tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Synpo2
Synpo2tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Synpo2
Synpo2tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Cflar
Cflartm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Cflar
Cflartm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Chrna1
Chrna1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Chrna1
Chrna1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Eftud2
Eftud2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Eftud2
Eftud2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Tti2
Tti2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Tti2
Tti2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Lmna
Lmnatm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Lmna
Lmnatm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Taf2
Taf2tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Taf2
Taf2tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Dcp2
Dcp2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Dcp2
Dcp2tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ect2
Ect2tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ect2
Ect2tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Atxn7l3
Atxn7l3tm1.1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Atxn7l3
Atxn7l3tm1.1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ppp6c
Ppp6ctm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ppp6c
Ppp6ctm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Coq6
Coq6tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Coq6
Coq6tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Dyrk1b
Dyrk1btm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Dyrk1b
Dyrk1btm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Mir124a-2
Mir124a-2tm1b(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Mir124a-2
Mir124a-2tm1b(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Yipf5
Yipf5tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Yipf5
Yipf5tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Atp6v1d
Atp6v1dtm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Atp6v1d
Atp6v1dtm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Morc3
Morc3tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Morc3
Morc3tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Nae1
Nae1tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Nae1
Nae1tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Myo18b
Myo18bem2Ics
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Myo18b
Myo18bem2Ics
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Derl2
Derl2tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Derl2
Derl2tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Rbfox1
Rbfox1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Rbfox1
Rbfox1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Il2ra
Il2ratm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Large intestine homozygote Male abnormal colon morphology 0.0
Fpr3
Fpr3tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Large intestine homozygote Male abnormal colon morphology 0.0
Cbl
Cbltm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Cbl
Cbltm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Ncs1
Ncs1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Ncs1
Ncs1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Parp1
Parp1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Parp1
Parp1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
5330417C22Rik
5330417C22Riktm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
5330417C22Rik
5330417C22Riktm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Klhl29
Klhl29tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Klhl29
Klhl29tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Pcsk1
Pcsk1tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Pcsk1
Pcsk1tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Aak1
Aak1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Aak1
Aak1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Ctsd
Ctsdtm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Ctsd
Ctsdtm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Cdon
Cdontm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Cdon
Cdontm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Dnal4
Dnal4tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Dnal4
Dnal4tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
App
Apptm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
App
Apptm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Ddr1
Ddr1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Ddr1
Ddr1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Ino80
Ino80tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Ino80
Ino80tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Pnpla1
Pnpla1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Pnpla1
Pnpla1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Trmt1
Trmt1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Trmt1
Trmt1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Gorasp1
Gorasp1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Gorasp1
Gorasp1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Sept3
Sept3tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Sept3
Sept3tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Zranb1
Zranb1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Zranb1
Zranb1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Setbp1
Setbp1tm1e.1(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Setbp1
Setbp1tm1e.1(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Thra
Thratm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Thra
Thratm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Tnfrsf9
Tnfrsf9tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Tnfrsf9
Tnfrsf9tm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Combined SHIRPA and Dysmorphology Activity (body position) hemizygote Female abnormal locomotor behavior 0.0
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Combined SHIRPA and Dysmorphology Activity (body position) hemizygote Male abnormal locomotor behavior 0.0
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Combined SHIRPA and Dysmorphology Vocalization hemizygote Female abnormal vocalization 0.0
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Combined SHIRPA and Dysmorphology Vocalization hemizygote Male abnormal vocalization 0.0
Cdk8
Cdk8tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E9.5 Heart morphology homozygote abnormal heart morphology 0.0
Fpr3
Fpr3tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Small intestine homozygote Male abnormal ileum morphology 0.0
Prkab1
Prkab1tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Eye with optic nerve homozygote Female anophthalmia 0.0
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Eye Morphology Persistence of hyaloid vascular system homozygote Female persistence of hyaloid vascular system 0.0
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Eye Morphology Persistence of hyaloid vascular system homozygote Male persistence of hyaloid vascular system 0.0
Prdm10
Prdm10tm1b(EUCOMM)Hmgu
Viability E12.5 Secondary Screen Outcome homozygote embryonic lethality prior to tooth bud stage 0.0
Yipf5
Yipf5tm1b(EUCOMM)Hmgu
Viability E12.5 Secondary Screen Outcome homozygote embryonic lethality prior to tooth bud stage 0.0
Otub1
Otub1tm1b(EUCOMM)Hmgu
Viability E12.5 Secondary Screen Outcome homozygote embryonic lethality prior to tooth bud stage 0.0
Ino80
Ino80tm1a(EUCOMM)Hmgu
Viability E12.5 Secondary Screen Outcome homozygote embryonic lethality prior to tooth bud stage 0.0
Cdk8
Cdk8tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E9.5 Neural tube closure homozygote abnormal neural tube closure 0.0
Sun1
Sun1tm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Uterus homozygote Female small superior vagus ganglion 0.0
Setx
Setxtm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Testes homozygote Male small testis 0.0
Sun1
Sun1tm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Testes homozygote Male small testis 0.0
Aak1
Aak1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 12kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 0.0
Aak1
Aak1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 18kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 0.0
Aak1
Aak1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 24kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 0.0
Aak1
Aak1tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 30kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 0.0
Fam207a
Fam207atm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 18kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 0.0
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Auditory Brain Stem Response 24kHz-evoked ABR Threshold hemizygote increased or absent threshold for auditory brainstem response 0.0
Dyrk1b
Dyrk1btm1b(EUCOMM)Wtsi
Auditory Brain Stem Response 30kHz-evoked ABR Threshold heterozygote increased or absent threshold for auditory brainstem response 0.0
Baiap2l2
Baiap2l2tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 6kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 0.0
Baiap2l2
Baiap2l2tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 12kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 0.0
Baiap2l2
Baiap2l2tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 18kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 0.0
Baiap2l2
Baiap2l2tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 24kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 0.0
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Auditory Brain Stem Response 6kHz-evoked ABR Threshold heterozygote increased or absent threshold for auditory brainstem response 0.0
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Auditory Brain Stem Response 12kHz-evoked ABR Threshold heterozygote increased or absent threshold for auditory brainstem response 0.0
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Auditory Brain Stem Response 18kHz-evoked ABR Threshold heterozygote increased or absent threshold for auditory brainstem response 0.0
Il2ra
Il2ratm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Lymph node homozygote Male enlarged lymph nodes 0.0
Il2ra
Il2ratm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Lymph node homozygote Female enlarged lymph nodes 0.0
Stat1
Stat1tm2b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Lymph node homozygote Female enlarged lymph nodes 0.0
Stat1
Stat1tm2b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Lymph node homozygote Male enlarged lymph nodes 0.0
Pigu
Pigutm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Brain heterozygote Female hydroencephaly 0.0
Trmt1
Trmt1tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Liver heterozygote Female abnormal liver morphology 0.0
Nab2
Nab2tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Liver homozygote Male abnormal liver morphology 0.0
Ntf5
Ntf5tm1b(EUCOMM)Hmgu
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Il2rb
Il2rbtm1b(EUCOMM)Hmgu
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Sun1
Sun1tm1b(EUCOMM)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Scaper
Scapertm1b(EUCOMM)Hmgu
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Setx
Setxtm1b(EUCOMM)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ccdc189
Ccdc189tm1b(EUCOMM)Hmgu
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Il2rb
Il2rbtm1b(EUCOMM)Hmgu
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Il18rap
Il18raptm1b(KOMP)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Sun1
Sun1tm1b(EUCOMM)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
4933430I17Rik
4933430I17Riktm1a(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Pancreas homozygote Male abnormal pancreas morphology 0.0
Il2ra
Il2ratm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Spleen homozygote Female abnormal spleen morphology 0.0
Il2ra
Il2ratm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Spleen homozygote Male abnormal spleen morphology 0.0
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Gross Pathology and Tissue Collection Spleen hemizygote Male abnormal spleen morphology 0.0
Mapt
Mapttm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Kidney homozygote Female polycystic kidney 0.0
Knstrn
Knstrntm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Seminal vesicle homozygote Male abnormal seminal vesicle morphology 0.0
Ino80
Ino80tm1a(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Seminal vesicle heterozygote Male abnormal seminal vesicle morphology 0.0
Ctsd
Ctsdtm1b(EUCOMM)Wtsi
Viability Primary Screen Additional Outcome homozygote Female premature death 0.0
Ctsd
Ctsdtm1b(EUCOMM)Wtsi
Viability Primary Screen Additional Outcome homozygote Male premature death 0.0
App
Apptm1b(KOMP)Wtsi
Viability Primary Screen Additional Outcome homozygote Female premature death 0.0
App
Apptm1b(KOMP)Wtsi
Viability Primary Screen Additional Outcome homozygote Male premature death 0.0
Pnpla1
Pnpla1tm1b(KOMP)Wtsi
Viability Primary Screen Additional Outcome homozygote Female premature death 0.0
Pnpla1
Pnpla1tm1b(KOMP)Wtsi
Viability Primary Screen Additional Outcome homozygote Male premature death 0.0
Trmt1
Trmt1tm1b(EUCOMM)Hmgu
Viability Primary Screen Additional Outcome homozygote Female premature death 0.0
Trmt1
Trmt1tm1b(EUCOMM)Hmgu
Viability Primary Screen Additional Outcome homozygote Male premature death 0.0
Setbp1
Setbp1tm1e.1(EUCOMM)Wtsi
Viability Primary Screen Additional Outcome homozygote Female premature death 0.0
Setbp1
Setbp1tm1e.1(EUCOMM)Wtsi
Viability Primary Screen Additional Outcome homozygote Male premature death 0.0
Trmt1
Trmt1tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Kidney heterozygote Female abnormal kidney morphology 0.0
Atad2b
Atad2btm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Kidney homozygote Female abnormal kidney morphology 0.0
Il2ra
Il2ratm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Small intestine homozygote Male abnormal duodenum morphology 0.0
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Combined SHIRPA and Dysmorphology Aggression hemizygote Female increased aggression 0.0
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Combined SHIRPA and Dysmorphology Aggression hemizygote Male increased aggression 0.0
Knstrn
Knstrntm1b(KOMP)Wtsi
Hematology Mean cell volume homozygote Female increased mean corpuscular volume 0.0
Knstrn
Knstrntm1b(KOMP)Wtsi
Hematology Mean cell volume homozygote Male increased mean corpuscular volume 0.0
Mmp9
Mmp9tm1b(EUCOMM)Wtsi
Heart Weight Tibia length homozygote Female short tibia 3.932043490895437E-42
Mmp9
Mmp9tm1b(EUCOMM)Wtsi
Heart Weight Tibia length homozygote Male short tibia 3.932043490895437E-42
Knstrn
Knstrntm1b(KOMP)Wtsi
Hematology Mean corpuscular hemoglobin homozygote Female increased mean corpuscular hemoglobin 2.5306805668412607E-39
Knstrn
Knstrntm1b(KOMP)Wtsi
Hematology Mean corpuscular hemoglobin homozygote Male increased mean corpuscular hemoglobin 2.5306805668412607E-39
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase heterozygote Female increased circulating alkaline phosphatase level 1.0616945880179366E-19
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase heterozygote Male increased circulating alkaline phosphatase level 1.0616945880179366E-19
Baiap2l2
Baiap2l2tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Startle response homozygote Male absent startle reflex 9.989326726307819E-19
Mmp11
Mmp11tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Male abnormal skin coloration 1.086560981399776E-18
Mmp11
Mmp11tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Female abnormal skin coloration 1.4236059583445874E-18
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Left anterior chamber depth homozygote Female abnormal eye anterior chamber depth 1.913161223355521E-17
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Left anterior chamber depth homozygote Male abnormal eye anterior chamber depth 1.913161223355521E-17
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Right vitreous humor thickness homozygote Female abnormal vitreous body morphology 8.14643267619133E-17
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Right vitreous humor thickness homozygote Male abnormal vitreous body morphology 8.14643267619133E-17
Knstrn
Knstrntm1b(KOMP)Wtsi
Hematology Red blood cell count homozygote Female decreased erythrocyte cell number 1.0145565427587447E-16
Knstrn
Knstrntm1b(KOMP)Wtsi
Hematology Red blood cell count homozygote Male decreased erythrocyte cell number 1.0145565427587447E-16
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry HDL-cholesterol heterozygote Female increased circulating HDL cholesterol level 2.7365326361005176E-16
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry HDL-cholesterol heterozygote Male increased circulating HDL cholesterol level 2.7365326361005176E-16
Aak1
Aak1tm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Female short tibia 3.208895382213455E-16
Aak1
Aak1tm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Male short tibia 3.208895382213455E-16
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry Total cholesterol heterozygote Female increased circulating cholesterol level 3.4276135828755004E-16
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry Total cholesterol heterozygote Male increased circulating cholesterol level 3.4276135828755004E-16
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - color - back heterozygote Male abnormal coat/hair pigmentation 7.160439077030735E-16
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - color - head heterozygote Male abnormal coat/hair pigmentation 7.160439077030735E-16
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Startle response heterozygote Female absent startle reflex 8.588304750832174E-16
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Forelimb digit - size homozygote Male abnormal digit morphology 1.2988570502204524E-15
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Forelimb digit - shape homozygote Male abnormal digit morphology 1.2988570502204524E-15
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry Albumin heterozygote Female increased circulating serum albumin level 1.8989070485166603E-15
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry Albumin heterozygote Male increased circulating serum albumin level 1.8989070485166603E-15
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Left vitreous humour thickness homozygote Female abnormal vitreous body morphology 5.46917993207198E-15
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Left vitreous humour thickness homozygote Male abnormal vitreous body morphology 5.46917993207198E-15
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - color - abdomen heterozygote Male abnormal coat/hair pigmentation 5.720744905758244E-15
Thra
Thratm1b(EUCOMM)Wtsi
Open Field Distance travelled - total heterozygote Female hyperactivity 9.713084354293251E-15
Thra
Thratm1b(EUCOMM)Wtsi
Open Field Distance travelled - total heterozygote Male hyperactivity 9.713084354293251E-15
Dnajc5b
Dnajc5btm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Female shortened QT interval 1.1322878940879522E-14
Dnajc5b
Dnajc5btm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male shortened QT interval 1.1322878940879522E-14
Snx29
Snx29tm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase homozygote Female increased circulating alkaline phosphatase level 2.3360989114288785E-14
Snx29
Snx29tm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase homozygote Male increased circulating alkaline phosphatase level 2.3360989114288785E-14
Aak1
Aak1tm1b(EUCOMM)Hmgu
Open Field Number of rears - total homozygote Female increased vertical activity 2.4357457308163584E-14
Aak1
Aak1tm1b(EUCOMM)Hmgu
Open Field Number of rears - total homozygote Male increased vertical activity 2.4357457308163584E-14
Tnfrsf9
Tnfrsf9tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Male abnormal bone structure 1.454481066837099E-13
Knstrn
Knstrntm1b(KOMP)Wtsi
Hematology Platelet count homozygote Female thrombocytopenia 2.633089059289606E-13
Knstrn
Knstrntm1b(KOMP)Wtsi
Hematology Platelet count homozygote Male thrombocytopenia 2.633089059289606E-13
Aak1
Aak1tm1b(EUCOMM)Hmgu
Heart Weight Tibia length homozygote Female short tibia 4.700449014391483E-13
Aak1
Aak1tm1b(EUCOMM)Hmgu
Heart Weight Tibia length homozygote Male short tibia 4.700449014391483E-13
Baiap2l2
Baiap2l2tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 1.1376523638070846E-12
Baiap2l2
Baiap2l2tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 1.1376523638070846E-12
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Center average speed homozygote Female abnormal behavior 1.3118684740950903E-12
Laptm4a
Laptm4atm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 1.4044468713003688E-12
Rnf10
Rnf10tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Unexpected behaviors homozygote Female abnormal behavior 1.9276448926658363E-12
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry Calcium heterozygote Female increased circulating calcium level 2.6851333656541243E-12
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry Calcium heterozygote Male increased circulating calcium level 2.6851333656541243E-12
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Distance travelled - total homozygote Female hyperactivity 5.3065499043547515E-12
Mmp9
Mmp9tm1b(EUCOMM)Wtsi
X-ray Tibia length homozygote Female short tibia 6.4125549488480704E-12
Mmp9
Mmp9tm1b(EUCOMM)Wtsi
X-ray Tibia length homozygote Male short tibia 6.4125549488480704E-12
Nol8
Nol8tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Female increased startle reflex 1.037177375234899E-11
Nol8
Nol8tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Male increased startle reflex 1.037177375234899E-11
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean homozygote Female decreased grip strength 1.054177925507993E-11
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean homozygote Male decreased grip strength 1.054177925507993E-11
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Female decreased grip strength 1.9038440962626524E-11
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Male decreased grip strength 1.9038440962626524E-11
Ptdss1
Ptdss1tm1b(EUCOMM)Hmgu
Clinical Chemistry Calcium homozygote Female increased circulating calcium level 2.5232985839673816E-11
Ptdss1
Ptdss1tm1b(EUCOMM)Hmgu
Clinical Chemistry Calcium homozygote Male increased circulating calcium level 2.5232985839673816E-11
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Right anterior chamber depth homozygote Female abnormal eye anterior chamber depth 3.016323996130055E-11
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Right anterior chamber depth homozygote Male abnormal eye anterior chamber depth 3.016323996130055E-11
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Eye Morphology Left outer nuclear layer heterozygote Female abnormal retinal outer nuclear layer morphology 4.0389566691168E-11
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Eye Morphology Left outer nuclear layer heterozygote Male abnormal retinal outer nuclear layer morphology 4.0389566691168E-11
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Right total retinal thickness homozygote Female decreased total retina thickness 1.1841704006254616E-10
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Right total retinal thickness homozygote Male decreased total retina thickness 1.1841704006254616E-10
Ino80
Ino80tm1a(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Locomotor activity heterozygote Female hypoactivity 1.3800270648456348E-10
Ino80
Ino80tm1a(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Locomotor activity heterozygote Male hypoactivity 1.3800270648456348E-10
Rab19
Rab19tm1b(EUCOMM)Hmgu
Hematology Large Unstained Cell (LUC) differential count homozygote Female decreased large unstained cell number 2.83089607311382E-10
Rab19
Rab19tm1b(EUCOMM)Hmgu
Hematology Large Unstained Cell (LUC) differential count homozygote Male decreased large unstained cell number 2.83089607311382E-10
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Eye Morphology Right outer nuclear layer heterozygote Female abnormal retinal outer nuclear layer morphology 3.7005415398638775E-10
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Eye Morphology Right outer nuclear layer heterozygote Male abnormal retinal outer nuclear layer morphology 3.7005415398638775E-10
Timm50
Timm50tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Male decreased bone mineral content 4.093775318736448E-10
Carmil2
Carmil2tm1b(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - back homozygote Female abnormal coat/hair pigmentation 4.151566868060286E-10
Carmil2
Carmil2tm1b(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Female abnormal coat/hair pigmentation 4.151566868060286E-10
Carmil2
Carmil2tm1b(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Female abnormal coat/hair pigmentation 4.151566868060286E-10
Pcsk1
Pcsk1tm1b(EUCOMM)Wtsi
Open Field Distance travelled - total heterozygote Female hypoactivity 4.919754048593461E-10
Pcsk1
Pcsk1tm1b(EUCOMM)Wtsi
Open Field Distance travelled - total homozygote Female hypoactivity 4.919754048593461E-10
Aak1
Aak1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 5.1679888146694E-10
Aak1
Aak1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 5.1679888146694E-10
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry Total protein heterozygote Female increased circulating total protein level 1.1971816871181318E-9
Eftud2
Eftud2tm1b(KOMP)Wtsi
Clinical Chemistry Total protein heterozygote Male increased circulating total protein level 1.1971816871181318E-9
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Female decreased startle reflex 1.2153680284399115E-9
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Male decreased startle reflex 1.2153680284399115E-9
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - size homozygote Male abnormal digit morphology 1.3484989791479052E-9
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb digit - shape homozygote Male abnormal digit morphology 1.3484989791479052E-9
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Distance travelled - total hemizygote Male hyperactivity 1.4959700145311672E-9
Rab19
Rab19tm1b(EUCOMM)Hmgu
Hematology Large Unstained Cell (LUC) count homozygote Female decreased large unstained cell number 2.3196693454963224E-9
Rab19
Rab19tm1b(EUCOMM)Hmgu
Hematology Large Unstained Cell (LUC) count homozygote Male decreased large unstained cell number 2.3196693454963224E-9
Il2ra
Il2ratm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Female improved glucose tolerance 3.253906033506837E-9
Il2ra
Il2ratm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Male improved glucose tolerance 3.253906033506837E-9
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Left total retinal thickness homozygote Female decreased total retina thickness 4.083164917290105E-9
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Left total retinal thickness homozygote Male decreased total retina thickness 4.083164917290105E-9
Nab2
Nab2tm1b(EUCOMM)Hmgu
Rotarod Latency to fall mean homozygote Female abnormal motor capabilities/coordination/movement 5.118828916295115E-9
Nab2
Nab2tm1b(EUCOMM)Hmgu
Rotarod Latency to fall mean homozygote Male abnormal motor capabilities/coordination/movement 5.118828916295115E-9
Dnal4
Dnal4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length heterozygote Female decreased body length 6.540175956359917E-9
Bmp10
Bmp10tm3b(EUCOMM)Hmgu
Clinical Chemistry Creatinine heterozygote Female decreased circulating creatinine level 9.140879164704074E-9
Bmp10
Bmp10tm3b(EUCOMM)Hmgu
Clinical Chemistry Creatinine heterozygote Male decreased circulating creatinine level 9.140879164704074E-9
Icos
Icostm2b(EUCOMM)Wtsi
X-ray Tibia length homozygote Female short tibia 9.733099659570144E-9
Icos
Icostm2b(EUCOMM)Wtsi
X-ray Tibia length homozygote Male short tibia 9.733099659570144E-9
Dcp2
Dcp2tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color pattern - back heterozygote Female abnormal coat/hair pigmentation 9.858694305364679E-9
Dcp2
Dcp2tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color pattern - head heterozygote Female abnormal coat/hair pigmentation 9.858694305364679E-9
Fam207a
Fam207atm1b(EUCOMM)Hmgu
Clinical Chemistry Total cholesterol homozygote Female increased circulating cholesterol level 1.0973219666254863E-8
Fam207a
Fam207atm1b(EUCOMM)Hmgu
Clinical Chemistry Total cholesterol homozygote Male increased circulating cholesterol level 1.0973219666254863E-8
Klhl29
Klhl29tm1b(EUCOMM)Hmgu
Echo HR homozygote Male increased heart rate 1.1126050303289503E-8
Il2ra
Il2ratm1b(EUCOMM)Wtsi
X-ray Shape of vertebrae homozygote Female abnormal vertebrae morphology 1.2005999749931107E-8
Rab19
Rab19tm1b(EUCOMM)Hmgu
Heart Weight Heart weight homozygote Male increased heart weight 1.2122947978809862E-8
Parp1
Parp1tm1b(EUCOMM)Hmgu
Eye Morphology Left total retinal thickness homozygote Female decreased total retina thickness 1.368481683527989E-8
Parp1
Parp1tm1b(EUCOMM)Hmgu
Eye Morphology Left total retinal thickness homozygote Male decreased total retina thickness 1.368481683527989E-8
Pcsk1
Pcsk1tm1b(EUCOMM)Wtsi
Open Field Periphery distance travelled heterozygote Female hypoactivity 1.5242365591916496E-8
Pcsk1
Pcsk1tm1b(EUCOMM)Wtsi
Open Field Periphery distance travelled homozygote Female hypoactivity 1.5242365591916496E-8
Laptm4a
Laptm4atm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Male prolonged ST segment 1.7144566655247218E-8
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean corpuscular hemoglobin homozygote Female decreased mean corpuscular hemoglobin 1.7232567373071106E-8
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean corpuscular hemoglobin homozygote Male decreased mean corpuscular hemoglobin 1.7232567373071106E-8
Prdm10
Prdm10tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat mass heterozygote Male decreased total body fat amount 2.1976781283683522E-8
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Periphery permanence time homozygote Female abnormal behavior 2.3602229504149363E-8
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Periphery permanence time homozygote Male abnormal behavior 2.3602229504149363E-8
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Center permanence time homozygote Female abnormal behavior 2.3619726619017456E-8
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Center permanence time homozygote Male abnormal behavior 2.3619726619017456E-8
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Percentage center time homozygote Female abnormal behavior 2.3619826095000462E-8
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Percentage center time homozygote Male abnormal behavior 2.3619826095000462E-8
Eftud2
Eftud2tm1b(KOMP)Wtsi
Hematology Platelet count heterozygote Female thrombocytosis 3.498388423395227E-8
Eftud2
Eftud2tm1b(KOMP)Wtsi
Hematology Platelet count heterozygote Male thrombocytosis 3.498388423395227E-8
Fam207a
Fam207atm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol homozygote Female increased circulating HDL cholesterol level 4.186261293170901E-8
Fam207a
Fam207atm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol homozygote Male increased circulating HDL cholesterol level 4.186261293170901E-8
Nab2
Nab2tm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol homozygote Female decreased circulating HDL cholesterol level 4.28074073965945E-8
Nab2
Nab2tm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol homozygote Male decreased circulating HDL cholesterol level 4.28074073965945E-8
Aak1
Aak1tm1b(EUCOMM)Hmgu
Clinical Chemistry Total protein homozygote Female decreased circulating total protein level 4.323067770428679E-8
Aak1
Aak1tm1b(EUCOMM)Hmgu
Clinical Chemistry Total protein homozygote Male decreased circulating total protein level 4.323067770428679E-8
Dcp2
Dcp2tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color pattern - abdomen heterozygote Female abnormal coat/hair pigmentation 4.904699935082135E-8
Il10ra
Il10ratm1b(KOMP)Wtsi
Hematology Neutrophil cell count homozygote Female increased neutrophil cell number 5.804018599064875E-8
Il10ra
Il10ratm1b(KOMP)Wtsi
Hematology Neutrophil cell count homozygote Male increased neutrophil cell number 5.804018599064875E-8
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Number of center entries homozygote Female abnormal behavior 6.22646396664095E-8
Prdm10
Prdm10tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass heterozygote Male increased lean body mass 6.604975055779505E-8
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Periphery distance travelled homozygote Female hyperactivity 6.792696893853645E-8
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean cell volume homozygote Female decreased mean corpuscular volume 7.403072288525436E-8
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean cell volume homozygote Male decreased mean corpuscular volume 7.403072288525436E-8
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Clinical Chemistry Albumin homozygote Female decreased circulating serum albumin level 8.546045648927247E-8
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Clinical Chemistry Albumin homozygote Male decreased circulating serum albumin level 8.546045648927247E-8
Ptdss1
Ptdss1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Female increased prepulse inhibition 1.041267339019214E-7
Ptdss1
Ptdss1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Male increased prepulse inhibition 1.041267339019214E-7
Dnm1l
Dnm1ltm1b(KOMP)Wtsi
Eye Morphology Persistence of hyaloid vascular system heterozygote Male persistence of hyaloid vascular system 1.0871829658753995E-7
App
Apptm1b(KOMP)Wtsi
Clinical Chemistry Urea (Blood Urea Nitrogen - BUN) heterozygote Female increased blood urea nitrogen level 1.1112618381048378E-7
App
Apptm1b(KOMP)Wtsi
Clinical Chemistry Urea (Blood Urea Nitrogen - BUN) heterozygote Male increased blood urea nitrogen level 1.1112618381048378E-7
4933430I17Rik
4933430I17Riktm1b(EUCOMM)Wtsi
Echo Fractional Shortening homozygote Female increased cardiac muscle contractility 1.2872088461790554E-7
Iah1
Iah1tm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Male short tibia 1.3880234916996415E-7
Dnajc5b
Dnajc5btm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Female shortened ST segment 1.405688010436279E-7
Dnajc5b
Dnajc5btm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) ST homozygote Male shortened ST segment 1.405688010436279E-7
Ntf5
Ntf5tm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol homozygote Female increased circulating HDL cholesterol level 1.6347121345461346E-7
Ntf5
Ntf5tm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol homozygote Male increased circulating HDL cholesterol level 1.6347121345461346E-7
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean cell hemoglobin concentration homozygote Female decreased mean corpuscular hemoglobin concentration 1.7304114408034366E-7
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Mean cell hemoglobin concentration homozygote Male decreased mean corpuscular hemoglobin concentration 1.7304114408034366E-7
Dyrk1b
Dyrk1btm1b(EUCOMM)Wtsi
Hematology Large Unstained Cell (LUC) differential count heterozygote Female decreased large unstained cell number 1.8594178641251347E-7
Dyrk1b
Dyrk1btm1b(EUCOMM)Wtsi
Hematology Large Unstained Cell (LUC) differential count heterozygote Male decreased large unstained cell number 1.8594178641251347E-7
Prdm10
Prdm10tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean/Body weight heterozygote Male increased lean body mass 2.098882418977155E-7
Nab2
Nab2tm1b(EUCOMM)Hmgu
Clinical Chemistry Total cholesterol homozygote Female decreased circulating cholesterol level 2.148516671240941E-7
Nab2
Nab2tm1b(EUCOMM)Hmgu
Clinical Chemistry Total cholesterol homozygote Male decreased circulating cholesterol level 2.148516671240941E-7
Ankrd27
Ankrd27tm1b(EUCOMM)Hmgu
Eye Morphology Right total retinal thickness homozygote Female decreased total retina thickness 2.2909740948762192E-7
Ankrd27
Ankrd27tm1b(EUCOMM)Hmgu
Eye Morphology Right total retinal thickness homozygote Male decreased total retina thickness 2.2909740948762192E-7
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Clinical Chemistry Glucose homozygote Male decreased circulating glucose level 2.346630054717025E-7
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Locomotor activity homozygote Male hypoactivity 2.3706104457232868E-7
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Locomotor activity heterozygote Male hypoactivity 2.3706104457232868E-7
Dcp2
Dcp2tm1b(KOMP)Wtsi
Heart Weight Heart weight heterozygote Female increased heart weight 2.3708099661234883E-7
Dcp2
Dcp2tm1b(KOMP)Wtsi
Heart Weight Heart weight heterozygote Male increased heart weight 2.3708099661234883E-7
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Left outer nuclear layer homozygote Female abnormal retinal outer nuclear layer morphology 2.7299282123749435E-7
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Left outer nuclear layer homozygote Male abnormal retinal outer nuclear layer morphology 2.7299282123749435E-7
Aak1
Aak1tm1b(EUCOMM)Hmgu
Eye Morphology Right anterior chamber depth homozygote Female abnormal eye anterior chamber depth 2.8155389486528293E-7
Aak1
Aak1tm1b(EUCOMM)Hmgu
Eye Morphology Right anterior chamber depth homozygote Male abnormal eye anterior chamber depth 2.8155389486528293E-7
Gp6
Gp6tm2b(EUCOMM)Hmgu
Hematology Lymphocyte cell count homozygote Female increased lymphocyte cell number 2.9522877298404637E-7
Gp6
Gp6tm2b(EUCOMM)Hmgu
Hematology Lymphocyte cell count homozygote Male increased lymphocyte cell number 2.9522877298404637E-7
Il10ra
Il10ratm1b(KOMP)Wtsi
Auditory Brain Stem Response 30kHz-evoked ABR Threshold homozygote increased or absent threshold for auditory brainstem response 3.000000106112566E-7
Ptafr
Ptafrtm1b(KOMP)Wtsi
Auditory Brain Stem Response 6kHz-evoked ABR Threshold homozygote decreased threshold for auditory brainstem response 3.000000106112566E-7
Gm12258
Gm12258tm1b(EUCOMM)Hmgu
Auditory Brain Stem Response 30kHz-evoked ABR Threshold homozygote decreased threshold for auditory brainstem response 3.000000106112566E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Female decreased grip strength 3.1385533816319366E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Male decreased grip strength 3.1385533816319366E-7
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Periphery average speed homozygote Female abnormal behavior 4.144888237078703E-7
Dbn1
Dbn1tm1b(KOMP)Wtsi
Eye Morphology Left total retinal thickness heterozygote Female decreased total retina thickness 4.3090827261949016E-7
Dbn1
Dbn1tm1b(KOMP)Wtsi
Eye Morphology Left total retinal thickness heterozygote Male decreased total retina thickness 4.3090827261949016E-7
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Eye Morphology Left total retinal thickness homozygote Female decreased total retina thickness 4.63514737703008E-7
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Eye Morphology Left total retinal thickness homozygote Male decreased total retina thickness 4.63514737703008E-7
Slc7a11
Slc7a11tm1b(EUCOMM)Wtsi
Clinical Chemistry Glucose homozygote Female increased circulating glucose level 4.6667889819218544E-7
Slc7a11
Slc7a11tm1b(EUCOMM)Wtsi
Clinical Chemistry Glucose homozygote Male increased circulating glucose level 4.6667889819218544E-7
Casq1
Casq1tm1b(EUCOMM)Wtsi
Clinical Chemistry Creatinine homozygote Female decreased circulating creatinine level 4.950089760313858E-7
Casq1
Casq1tm1b(EUCOMM)Wtsi
Clinical Chemistry Creatinine homozygote Male decreased circulating creatinine level 4.950089760313858E-7
Gm12258
Gm12258tm1b(EUCOMM)Hmgu
Indirect Calorimetry Respiratory Exchange Ratio homozygote Female decreased respiratory quotient 5.403137492976384E-7
Gm12258
Gm12258tm1b(EUCOMM)Hmgu
Indirect Calorimetry Respiratory Exchange Ratio homozygote Male decreased respiratory quotient 5.403137492976384E-7
Dcaf7
Dcaf7tm1b(EUCOMM)Wtsi
Clinical Chemistry Total protein heterozygote Female increased circulating total protein level 5.44445526884374E-7
Dcaf7
Dcaf7tm1b(EUCOMM)Wtsi
Clinical Chemistry Total protein heterozygote Male increased circulating total protein level 5.44445526884374E-7
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Hindlimb nail - length homozygote Female abnormal nail morphology 5.620938736683456E-7
Tmem63b
Tmem63btm1b(EUCOMM)Wtsi
Open Field Number of center entries heterozygote Female abnormal behavior 5.715119755222986E-7
Tmem63b
Tmem63btm1b(EUCOMM)Wtsi
Open Field Number of center entries heterozygote Male abnormal behavior 5.715119755222986E-7
Yipf5
Yipf5tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 heterozygote Female increased prepulse inhibition 5.885891596335568E-7
Yipf5
Yipf5tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 heterozygote Male increased prepulse inhibition 5.885891596335568E-7
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Female decreased startle reflex 6.224471462701331E-7
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Male decreased startle reflex 6.224471462701331E-7
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Right outer nuclear layer homozygote Female abnormal retinal outer nuclear layer morphology 6.29021315035061E-7
Rspo1
Rspo1tm2b(KOMP)Wtsi
Eye Morphology Right outer nuclear layer homozygote Male abnormal retinal outer nuclear layer morphology 6.29021315035061E-7
Mbd5
Mbd5tm1b(EUCOMM)Wtsi
Open Field Center distance travelled heterozygote Female abnormal behavior 6.378477337420918E-7
Mbd5
Mbd5tm1b(EUCOMM)Wtsi
Open Field Center distance travelled heterozygote Male abnormal behavior 6.378477337420918E-7
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
X-ray Digit integrity homozygote Male abnormal digit morphology 6.396984986167809E-7
D16Ertd472e
D16Ertd472etm1b(EUCOMM)Wtsi
Eye Morphology Right vitreous humor thickness homozygote Female abnormal vitreous body morphology 6.765065450053953E-7
D16Ertd472e
D16Ertd472etm1b(EUCOMM)Wtsi
Eye Morphology Right vitreous humor thickness homozygote Male abnormal vitreous body morphology 6.765065450053953E-7
Tmem63b
Tmem63btm1b(EUCOMM)Wtsi
Eye Morphology Corneal mineralization heterozygote Male abnormal cornea morphology 6.853196055089938E-7
Slc7a11
Slc7a11tm1b(EUCOMM)Wtsi
Eye Morphology Right vitreous humor thickness homozygote Female abnormal vitreous body morphology 6.87431679580186E-7
Slc7a11
Slc7a11tm1b(EUCOMM)Wtsi
Eye Morphology Right vitreous humor thickness homozygote Male abnormal vitreous body morphology 6.87431679580186E-7
Bmp10
Bmp10tm3b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge heterozygote Female improved glucose tolerance 7.047030408102728E-7
Bmp10
Bmp10tm3b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge heterozygote Male improved glucose tolerance 7.047030408102728E-7
Lrrc3
Lrrc3tm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol homozygote Female increased circulating HDL cholesterol level 7.371975243586348E-7
Lrrc3
Lrrc3tm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol homozygote Male increased circulating HDL cholesterol level 7.371975243586348E-7
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Center distance travelled homozygote Female abnormal behavior 7.415081881845254E-7
Ankrd27
Ankrd27tm1b(EUCOMM)Hmgu
Eye Morphology Left total retinal thickness homozygote Female decreased total retina thickness 7.430459731949668E-7
Ankrd27
Ankrd27tm1b(EUCOMM)Hmgu
Eye Morphology Left total retinal thickness homozygote Male decreased total retina thickness 7.430459731949668E-7
Rnf10
Rnf10tm1b(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean homozygote Female decreased grip strength 7.735557687738037E-7
Rnf10
Rnf10tm1b(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean homozygote Male decreased grip strength 7.735557687738037E-7
Mbd5
Mbd5tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) RR heterozygote Female shortened RR interval 8.102657602648833E-7
Mbd5
Mbd5tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) RR heterozygote Male shortened RR interval 8.102657602648833E-7
Med25
Med25tm1b(KOMP)Wtsi
Heart Weight Tibia length heterozygote Female short tibia 8.485881721753685E-7
Cbl
Cbltm1b(EUCOMM)Hmgu
Echo LVAWd heterozygote Male increased heart left ventricle size 8.735382834856864E-7
Cbl
Cbltm1b(EUCOMM)Hmgu
Echo LVAWd homozygote Male increased heart left ventricle size 8.735382834856864E-7
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Open Field Whole arena average speed homozygote Female hypoactivity 8.832352591525705E-7
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Open Field Whole arena average speed homozygote Male hypoactivity 8.832352591525705E-7
Parp1
Parp1tm1b(EUCOMM)Hmgu
Eye Morphology Right total retinal thickness homozygote Female decreased total retina thickness 9.057218335328798E-7
Parp1
Parp1tm1b(EUCOMM)Hmgu
Eye Morphology Right total retinal thickness homozygote Male decreased total retina thickness 9.057218335328798E-7
App
Apptm1b(KOMP)Wtsi
Clinical Chemistry Total bilirubin heterozygote Female decreased circulating bilirubin level 9.635733704271843E-7
App
Apptm1b(KOMP)Wtsi
Clinical Chemistry Total bilirubin heterozygote Male decreased circulating bilirubin level 9.635733704271843E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female decreased total body fat amount 9.745967872731853E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 9.745967872731853E-7
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Clinical Chemistry Total protein homozygote Female decreased circulating total protein level 9.942456244971254E-7
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Clinical Chemistry Total protein homozygote Male decreased circulating total protein level 9.942456244971254E-7
Atad2b
Atad2btm1b(EUCOMM)Hmgu
Open Field Center average speed homozygote Female abnormal behavior 1.0194581818723236E-6
Atad2b
Atad2btm1b(EUCOMM)Hmgu
Open Field Center average speed homozygote Male abnormal behavior 1.0194581818723236E-6
Sdsl
Sdsltm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 1.051754907166469E-6
Sdsl
Sdsltm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 1.051754907166469E-6
Mtmr12
Mtmr12tm1b(KOMP)Wtsi
Heart Weight Heart weight homozygote Female increased heart weight 1.160401893685048E-6
Mtmr12
Mtmr12tm1b(KOMP)Wtsi
Heart Weight Heart weight homozygote Male decreased heart weight 1.160401893685048E-6
Plekhg3
Plekhg3tm1b(EUCOMM)Hmgu
Eye Morphology Right anterior chamber depth homozygote Female abnormal eye anterior chamber depth 1.211494918607059E-6
Plekhg3
Plekhg3tm1b(EUCOMM)Hmgu
Eye Morphology Right anterior chamber depth homozygote Male abnormal eye anterior chamber depth 1.211494918607059E-6
Dusp11
Dusp11tm1b(EUCOMM)Wtsi
Eye Morphology Right corneal thickness homozygote Female decreased cornea thickness 1.268567416445876E-6
Casq1
Casq1tm1b(EUCOMM)Wtsi
Clinical Chemistry Total protein homozygote Female increased circulating total protein level 1.3206163202994503E-6
Casq1
Casq1tm1b(EUCOMM)Wtsi
Clinical Chemistry Total protein homozygote Male increased circulating total protein level 1.3206163202994503E-6
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
X-ray Digit integrity homozygote Female abnormal digit morphology 1.3634510196425254E-6
Stradb
Stradbtm1b(KOMP)Wtsi
Hematology Mean cell volume homozygote Female decreased mean corpuscular volume 1.376969407829165E-6
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol heterozygote Female increased circulating HDL cholesterol level 1.3777811318504973E-6
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Clinical Chemistry HDL-cholesterol heterozygote Male increased circulating HDL cholesterol level 1.3777811318504973E-6
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Auditory Brain Stem Response 30kHz-evoked ABR Threshold hemizygote increased or absent threshold for auditory brainstem response 1.3999999737279722E-6
Ptafr
Ptafrtm1b(KOMP)Wtsi
Auditory Brain Stem Response 12kHz-evoked ABR Threshold homozygote decreased threshold for auditory brainstem response 1.3999999737279722E-6
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Clinical Chemistry Total cholesterol heterozygote Male increased circulating cholesterol level 1.60863316978066E-6
Ankrd27
Ankrd27tm1b(EUCOMM)Hmgu
Heart Weight Tibia length homozygote Female short tibia 1.6227936612267513E-6
Ankrd27
Ankrd27tm1b(EUCOMM)Hmgu
Heart Weight Tibia length homozygote Male short tibia 1.6227936612267513E-6
Prdm10
Prdm10tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male decreased total body fat amount 1.7196563248944585E-6
Ino80
Ino80tm1a(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Body length heterozygote Female increased body length 1.7661873243923765E-6
Ino80
Ino80tm1a(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Body length heterozygote Male increased body length 1.7661873243923765E-6
Obp2a
Obp2atm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Coat - color - back homozygote Female abnormal coat/hair pigmentation 1.8870090343625634E-6
Obp2a
Obp2atm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Female abnormal coat/hair pigmentation 1.8870090343625634E-6
Obp2a
Obp2atm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Female abnormal coat/hair pigmentation 1.8870090343625634E-6
Ntf5
Ntf5tm1b(EUCOMM)Hmgu
Clinical Chemistry Total cholesterol homozygote Female increased circulating cholesterol level 1.9189844806533074E-6
Ntf5
Ntf5tm1b(EUCOMM)Hmgu
Clinical Chemistry Total cholesterol homozygote Male increased circulating cholesterol level 1.9189844806533074E-6
Rwdd3
Rwdd3tm1b(KOMP)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean heterozygote Male decreased grip strength 1.975871327886125E-6
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Latency to center entry homozygote Female abnormal behavior 1.9760752820729977E-6
Coq6
Coq6tm1b(EUCOMM)Hmgu
Eye Morphology Persistence of hyaloid vascular system heterozygote Male persistence of hyaloid vascular system 1.9851490833389107E-6
Lcp2
Lcp2tm1b(KOMP)Wtsi
Eye Morphology Lens Opacity heterozygote Male cataract 2.0932179722876754E-6
Lcp2
Lcp2tm1b(KOMP)Wtsi
Eye Morphology Lens heterozygote Male abnormal lens morphology 2.0932179722876754E-6
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Number of rears - total homozygote Female increased vertical activity 2.1836387986695627E-6
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Number of rears - total homozygote Male increased vertical activity 2.1836387986695627E-6
Slc7a11
Slc7a11tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male increased lean body mass 2.208620117016835E-6
Rnf10
Rnf10tm1b(KOMP)Wtsi
Clinical Chemistry Total protein homozygote Male decreased circulating total protein level 2.2721674213244114E-6
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Head morphology homozygote Male abnormal head morphology 2.3451750621461542E-6
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Auditory Brain Stem Response 24kHz-evoked ABR Threshold heterozygote increased or absent threshold for auditory brainstem response 2.4000000848900527E-6
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length heterozygote Female decreased body length 2.42161354435666E-6
Ankrd11
Ankrd11tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length heterozygote Male decreased body length 2.42161354435666E-6
Med25
Med25tm1b(KOMP)Wtsi
Rotarod Latency to fall mean heterozygote Female abnormal motor capabilities/coordination/movement 2.5469819320278475E-6
Med25
Med25tm1b(KOMP)Wtsi
Rotarod Latency to fall mean heterozygote Male abnormal motor capabilities/coordination/movement 2.5469819320278475E-6
Eftud2
Eftud2tm1b(KOMP)Wtsi
Hematology White blood cell count heterozygote Female decreased leukocyte cell number 2.548837755966815E-6
Eftud2
Eftud2tm1b(KOMP)Wtsi
Hematology White blood cell count heterozygote Male decreased leukocyte cell number 2.548837755966815E-6
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Eye Morphology Lens heterozygote Female abnormal lens morphology 2.555783112256904E-6
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Grip Strength Forelimb grip strength measurement mean heterozygote Female decreased grip strength 2.563680936873425E-6
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Grip Strength Forelimb grip strength measurement mean heterozygote Male decreased grip strength 2.563680936873425E-6
Iah1
Iah1tm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase homozygote Female decreased circulating alkaline phosphatase level 2.6092518510267837E-6
Pax4
Pax4tm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase heterozygote Female increased circulating alkaline phosphatase level 2.6243526463076705E-6
Pax4
Pax4tm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase heterozygote Male increased circulating alkaline phosphatase level 2.6243526463076705E-6
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Eye Morphology Corneal opacity heterozygote Male corneal opacity 2.657445975273731E-6
Gpr101
Gpr101tm1b(KOMP)Mbp
Hematology Eosinophil differential count homozygote Female decreased eosinophil cell number 2.6724567305791425E-6
Myo18b
Myo18bem2Ics
Clinical Chemistry Triglycerides heterozygote Male increased circulating triglyceride level 2.7572036742640194E-6
Rnf10
Rnf10tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Unexpected behaviors homozygote Male abnormal behavior 2.767965952443774E-6
Nab2
Nab2tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Unexpected behaviors homozygote Male abnormal behavior 2.767965952443774E-6
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Whole arena resting time hemizygote Male hyperactivity 2.834407041518716E-6
Dusp11
Dusp11tm1b(EUCOMM)Wtsi
Eye Morphology Right total retinal thickness homozygote Female decreased total retina thickness 2.856014134522411E-6
Dusp11
Dusp11tm1b(EUCOMM)Wtsi
Eye Morphology Right total retinal thickness homozygote Male decreased total retina thickness 2.856014134522411E-6
Sh3tc1
Sh3tc1tm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Male short tibia 2.950783937194501E-6
Sh3tc1
Sh3tc1tm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Female long tibia 2.950783937194501E-6
Timm50
Timm50tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male decreased total body fat amount 2.9668906336155487E-6
Klhl29
Klhl29tm1b(EUCOMM)Hmgu
Echo Fractional Shortening homozygote Male increased cardiac muscle contractility 3.0746846277907025E-6
Tmem63b
Tmem63btm1b(EUCOMM)Wtsi
Open Field Center distance travelled heterozygote Female abnormal behavior 3.097230774073978E-6
Tmem63b
Tmem63btm1b(EUCOMM)Wtsi
Open Field Center distance travelled heterozygote Male abnormal behavior 3.097230774073978E-6
Rnf10
Rnf10tm1b(KOMP)Wtsi
Clinical Chemistry Albumin homozygote Male decreased circulating serum albumin level 3.1785352803126443E-6
Synpo2
Synpo2tm1b(EUCOMM)Wtsi
Hematology Lymphocyte cell count heterozygote Female decreased lymphocyte cell number 3.25288851854566E-6
Synpo2
Synpo2tm1b(EUCOMM)Wtsi
Hematology Lymphocyte cell count heterozygote Male decreased lymphocyte cell number 3.25288851854566E-6
Setx
Setxtm1b(EUCOMM)Wtsi
Hematology Lymphocyte cell count homozygote Female decreased lymphocyte cell number 3.2589973670837935E-6
Setx
Setxtm1b(EUCOMM)Wtsi
Hematology Lymphocyte cell count homozygote Male decreased lymphocyte cell number 3.2589973670837935E-6
Timm50
Timm50tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass heterozygote Male increased lean body mass 3.267138254159363E-6
Scaper
Scapertm1b(EUCOMM)Hmgu
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Female decreased grip strength 3.287864501544391E-6
Scaper
Scapertm1b(EUCOMM)Hmgu
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Male decreased grip strength 3.287864501544391E-6
Gpr108
Gpr108tm1b(EUCOMM)Hmgu
Heart Weight Tibia length homozygote Female short tibia 3.358175490575377E-6
Gpr108
Gpr108tm1b(EUCOMM)Hmgu
Heart Weight Tibia length homozygote Male short tibia 3.358175490575377E-6
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 3.443809418968158E-6
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 3.443809418968158E-6
Carmil2
Carmil2tm1b(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - back homozygote Male abnormal coat/hair pigmentation 3.827195087069413E-6
Carmil2
Carmil2tm1b(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Male abnormal coat/hair pigmentation 3.827195087069413E-6
Carmil2
Carmil2tm1b(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Male abnormal coat/hair pigmentation 3.827195087069413E-6
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Eye Morphology Lens Opacity heterozygote Female cataract 3.85030898542027E-6
Rspo1
Rspo1tm2b(KOMP)Wtsi
Hematology White blood cell count homozygote Female increased leukocyte cell number 3.876063601637725E-6
Rspo1
Rspo1tm2b(KOMP)Wtsi
Hematology White blood cell count homozygote Male decreased leukocyte cell number 3.876063601637725E-6
Ahsa2
Ahsa2tm1b(EUCOMM)Wtsi
Eye Morphology Right total retinal thickness homozygote Female decreased total retina thickness 3.987201125710271E-6
Ahsa2
Ahsa2tm1b(EUCOMM)Wtsi
Eye Morphology Right total retinal thickness homozygote Male decreased total retina thickness 3.987201125710271E-6
Rnf10
Rnf10tm1b(KOMP)Wtsi
Clinical Chemistry Total cholesterol homozygote Female decreased circulating cholesterol level 4.0291843106388114E-6
Rnf10
Rnf10tm1b(KOMP)Wtsi
Clinical Chemistry Total cholesterol homozygote Male decreased circulating cholesterol level 4.0291843106388114E-6
Bahd1
Bahd1tm2b(KOMP)Wtsi
Hematology Lymphocyte cell count heterozygote Female decreased lymphocyte cell number 4.155954229645431E-6
Bahd1
Bahd1tm2b(KOMP)Wtsi
Hematology Lymphocyte cell count heterozygote Male decreased lymphocyte cell number 4.155954229645431E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Female increased lean body mass 4.166844064457109E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male increased lean body mass 4.166844064457109E-6
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Hemoglobin homozygote Female decreased hemoglobin content 4.240394900989486E-6
Prkab1
Prkab1tm1b(KOMP)Wtsi
Hematology Hemoglobin homozygote Male decreased hemoglobin content 4.240394900989486E-6
Kansl1
Kansl1tm1b(EUCOMM)Hmgu
Eye Morphology Cornea heterozygote Male abnormal cornea morphology 4.2438691707502585E-6
Tmem63b
Tmem63btm1b(EUCOMM)Wtsi
Open Field Distance travelled - total heterozygote Female hyperactivity 4.376486231194576E-6
Tmem63b
Tmem63btm1b(EUCOMM)Wtsi
Open Field Distance travelled - total heterozygote Male hyperactivity 4.376486231194576E-6
Med25
Med25tm1b(KOMP)Wtsi
Open Field Number of center entries heterozygote Female abnormal behavior 4.457860541151604E-6
Med25
Med25tm1b(KOMP)Wtsi
Open Field Number of center entries heterozygote Male abnormal behavior 4.457860541151604E-6
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Center distance travelled homozygote Female abnormal behavior 4.460498530534096E-6
Nab2
Nab2tm1b(EUCOMM)Hmgu
Open Field Center distance travelled homozygote Male abnormal behavior 4.460498530534096E-6
Pigu
Pigutm1b(EUCOMM)Hmgu
X-ray Joints heterozygote Male abnormal joint morphology 4.628122951544356E-6
Cdc26
Cdc26tm1b(EUCOMM)Hmgu
X-ray Joints heterozygote Male abnormal joint morphology 4.628122951544356E-6
Ncs1
Ncs1tm1b(EUCOMM)Hmgu
X-ray Joints homozygote Male abnormal joint morphology 4.628122951544356E-6
Kctd15
Kctd15tm1b(EUCOMM)Wtsi
X-ray Joints heterozygote Male abnormal joint morphology 4.628122951544356E-6
Ahsa2
Ahsa2tm1b(EUCOMM)Wtsi
X-ray Joints homozygote Male abnormal joint morphology 4.628122951544356E-6
Synpo2
Synpo2tm1b(EUCOMM)Wtsi
X-ray Joints heterozygote Male abnormal joint morphology 4.628122951544356E-6
Chrna1
Chrna1tm1b(EUCOMM)Hmgu
X-ray Joints heterozygote Male abnormal joint morphology 4.628122951544356E-6
Plekhg3
Plekhg3tm1b(EUCOMM)Hmgu
X-ray Joints homozygote Male abnormal joint morphology 4.628122951544356E-6
Yipf5
Yipf5tm1b(EUCOMM)Hmgu
X-ray Joints heterozygote Male abnormal joint morphology 4.628122951544356E-6
Ptdss1
Ptdss1tm1b(EUCOMM)Hmgu
X-ray Joints homozygote Male abnormal joint morphology 4.628122951544356E-6
Nae1
Nae1tm1b(EUCOMM)Wtsi
X-ray Joints heterozygote Male abnormal joint morphology 4.628122951544356E-6
Dpp4
Dpp4tm1b(EUCOMM)Wtsi
Auditory Brain Stem Response 30kHz-evoked ABR Threshold homozygote decreased threshold for auditory brainstem response 4.699999863078119E-6
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Periphery resting time hemizygote Male hyperactivity 4.7102284952416085E-6
Aak1
Aak1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Female abnormal sensory capabilities/reflexes/nociception 4.81857796330587E-6
Aak1
Aak1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Male abnormal sensory capabilities/reflexes/nociception 4.81857796330587E-6
Rwdd3
Rwdd3tm1b(KOMP)Wtsi
Open Field Center distance travelled heterozygote Female abnormal behavior 4.844961949856952E-6
Rwdd3
Rwdd3tm1b(KOMP)Wtsi
Open Field Center distance travelled heterozygote Male abnormal behavior 4.844961949856952E-6
Rnf144b
Rnf144btm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Vocalization homozygote Male abnormal vocalization 4.928027919959277E-6
Dusp11
Dusp11tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Activity (body position) homozygote Female abnormal locomotor behavior 4.931208877678728E-6
Mmp11
Mmp11tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Tail - morphology homozygote Female abnormal tail morphology 5.025961854698835E-6
Ntf5
Ntf5tm1b(EUCOMM)Hmgu
Clinical Chemistry Triglycerides homozygote Female decreased circulating triglyceride level 5.120918558532139E-6
Ntf5
Ntf5tm1b(EUCOMM)Hmgu
Clinical Chemistry Triglycerides homozygote Male decreased circulating triglyceride level 5.120918558532139E-6
Bahd1
Bahd1tm2b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Male increased startle reflex 5.132086243975209E-6
Pax4
Pax4tm1b(EUCOMM)Hmgu
Clinical Chemistry Total protein heterozygote Female increased circulating total protein level 5.213418262428604E-6
Pax4
Pax4tm1b(EUCOMM)Hmgu
Clinical Chemistry Total protein heterozygote Male increased circulating total protein level 5.213418262428604E-6
Slc7a11
Slc7a11tm1b(EUCOMM)Wtsi
Eye Morphology Left vitreous humour thickness homozygote Female abnormal vitreous body morphology 5.290215085551608E-6
Slc7a11
Slc7a11tm1b(EUCOMM)Wtsi
Eye Morphology Left vitreous humour thickness homozygote Male abnormal vitreous body morphology 5.290215085551608E-6
Med25
Med25tm1b(KOMP)Wtsi
Auditory Brain Stem Response 30kHz-evoked ABR Threshold heterozygote increased or absent threshold for auditory brainstem response 5.299999884300632E-6
Il10ra
Il10ratm1b(KOMP)Wtsi
Hematology Neutrophil differential count homozygote Female increased neutrophil cell number 5.3470339480554685E-6
Il10ra
Il10ratm1b(KOMP)Wtsi
Hematology Neutrophil differential count homozygote Male increased neutrophil cell number 5.3470339480554685E-6
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Open Field Center average speed homozygote Female abnormal behavior 5.381595201470191E-6
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Open Field Center average speed homozygote Male abnormal behavior 5.381595201470191E-6
Ptdss1
Ptdss1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI2 homozygote Female increased prepulse inhibition 5.408213382906979E-6
Ptdss1
Ptdss1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI2 homozygote Male increased prepulse inhibition 5.408213382906979E-6
D16Ertd472e
D16Ertd472etm1b(EUCOMM)Wtsi
Eye Morphology Left total retinal thickness homozygote Female decreased total retina thickness 5.414874067355413E-6
D16Ertd472e
D16Ertd472etm1b(EUCOMM)Wtsi
Eye Morphology Left total retinal thickness homozygote Male decreased total retina thickness 5.414874067355413E-6
Coq6
Coq6tm1b(EUCOMM)Hmgu
Eye Morphology Vitreous heterozygote Female abnormal vitreous body morphology 5.424466053227661E-6
Slc7a11
Slc7a11tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 5.43788519280497E-6
Parp1
Parp1tm1b(EUCOMM)Hmgu
Eye Morphology Right inner nuclear layer homozygote Female abnormal retinal inner nuclear layer morphology 5.492254331329605E-6
Parp1
Parp1tm1b(EUCOMM)Hmgu
Eye Morphology Right inner nuclear layer homozygote Male abnormal retinal inner nuclear layer morphology 5.492254331329605E-6
Ddr1
Ddr1tm1b(EUCOMM)Hmgu
Open Field Center resting time heterozygote Female abnormal behavior 5.661232989950804E-6
Ddr1
Ddr1tm1b(EUCOMM)Hmgu
Open Field Center resting time heterozygote Male abnormal behavior 5.661232989950804E-6
Klhl29
Klhl29tm1b(EUCOMM)Hmgu
Echo LVIDs homozygote Male abnormal heart left ventricle morphology 5.7546189964341465E-6
Laptm4a
Laptm4atm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Female short tibia 5.781051640951773E-6
Pigu
Pigutm1b(EUCOMM)Hmgu
X-ray Joints heterozygote Female abnormal joint morphology 5.830726877320558E-6
Cdc26
Cdc26tm1b(EUCOMM)Hmgu
X-ray Joints heterozygote Female abnormal joint morphology 5.830726877320558E-6
Ncs1
Ncs1tm1b(EUCOMM)Hmgu
X-ray Joints homozygote Female abnormal joint morphology 5.830726877320558E-6
Kctd15
Kctd15tm1b(EUCOMM)Wtsi
X-ray Joints heterozygote Female abnormal joint morphology 5.830726877320558E-6
Ahsa2
Ahsa2tm1b(EUCOMM)Wtsi
X-ray Joints homozygote Female abnormal joint morphology 5.830726877320558E-6
Synpo2
Synpo2tm1b(EUCOMM)Wtsi
X-ray Joints heterozygote Female abnormal joint morphology 5.830726877320558E-6
Chrna1
Chrna1tm1b(EUCOMM)Hmgu
X-ray Joints heterozygote Female abnormal joint morphology 5.830726877320558E-6
Plekhg3
Plekhg3tm1b(EUCOMM)Hmgu
X-ray Joints homozygote Female abnormal joint morphology 5.830726877320558E-6
Yipf5
Yipf5tm1b(EUCOMM)Hmgu
X-ray Joints heterozygote Female abnormal joint morphology 5.830726877320558E-6
Ptdss1
Ptdss1tm1b(EUCOMM)Hmgu
X-ray Joints homozygote Female abnormal joint morphology 5.830726877320558E-6
Nae1
Nae1tm1b(EUCOMM)Wtsi
X-ray Joints heterozygote Female abnormal joint morphology 5.830726877320558E-6
Rab19
Rab19tm1b(EUCOMM)Hmgu
X-ray Joints homozygote Female abnormal joint morphology 5.830726877320558E-6
Il18rap
Il18raptm1b(KOMP)Wtsi
Eye Morphology Left anterior chamber depth homozygote Female abnormal eye anterior chamber depth 5.9223057178314775E-6
Il18rap
Il18raptm1b(KOMP)Wtsi
Eye Morphology Left anterior chamber depth homozygote Male abnormal eye anterior chamber depth 5.9223057178314775E-6
Exd1
Exd1tm1b(EUCOMM)Hmgu
Heart Weight Heart weight homozygote Female increased heart weight 5.953942491032649E-6
Exd1
Exd1tm1b(EUCOMM)Hmgu
Heart Weight Heart weight homozygote Male increased heart weight 5.953942491032649E-6
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Open Field Whole arena average speed homozygote Female hypoactivity 6.189698979142122E-6
Pgam5
Pgam5tm1b(EUCOMM)Wtsi
Open Field Whole arena average speed homozygote Male hypoactivity 6.189698979142122E-6
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Open Field Periphery distance travelled hemizygote Male hyperactivity 6.2108169913699385E-6
Timm50
Timm50tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass heterozygote Male decreased total body fat amount 6.343305813061306E-6
Iah1
Iah1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Female prolonged QT interval 6.44931196802645E-6
Iah1
Iah1tm1b(EUCOMM)Hmgu
Electrocardiogram (ECG) QTc homozygote Male prolonged QT interval 6.44931196802645E-6
Smc5
Smc5tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tremor heterozygote Female tremors 6.533320174639812E-6
Aak1
Aak1tm1b(EUCOMM)Hmgu
Clinical Chemistry Albumin homozygote Female decreased circulating serum albumin level 6.6961174525204115E-6
Aak1
Aak1tm1b(EUCOMM)Hmgu
Clinical Chemistry Albumin homozygote Male decreased circulating serum albumin level 6.6961174525204115E-6
Prdm10
Prdm10tm1b(EUCOMM)Hmgu
Grip Strength Forelimb and hindlimb grip strength measurement mean heterozygote Male decreased grip strength 6.7023256633547135E-6
Nlk
Nlktm2b(KOMP)Wtsi
Auditory Brain Stem Response 30kHz-evoked ABR Threshold heterozygote increased or absent threshold for auditory brainstem response 7.000000096013537E-6
Ptchd1
Ptchd1tm1b(KOMP)IcsOrl
Combined SHIRPA and Dysmorphology Locomotor activity homozygote Female hyperactivity 7.0442315518448595E-6